Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid

American Journal of Preventive Medicine
Donatus U EkwuemeJustin Trogdon

Abstract

A few studies have examined the costs of breast cancer treatment in a Medicaid population at the state level. However, no study has estimated medical costs for breast cancer treatment at the national level for women aged 19-44 years enrolled in Medicaid. A sample of 5,542 younger women aged 19-44 years enrolled in fee-for-service Medicaid with diagnosis codes for breast cancer in 2007 were compared with 4.3 million women aged 19-44 years enrolled in fee-for-service Medicaid without breast cancer. Nonlinear regression methods estimated prevalent treatment costs for younger women with breast cancer compared with those without breast cancer. Individual medical costs were estimated by race/ethnicity and by type of services. Analyses were conducted in 2013 and all medical treatment costs were adjusted to 2012 U.S. dollars. The estimated monthly direct medical costs for breast cancer treatment among younger women enrolled in Medicaid was $5,711 (95% CI=$5,039, $6,383) per woman. The estimated monthly cost for outpatient services was $4,058 (95% CI=$3,575, $4,541), for inpatient services was $1,003 (95% CI=$708, $1,298), and for prescription drugs was $539 (95% CI=$431, $647). By race/ethnicity, non-Hispanic white women had the highes...Continue Reading

References

Jan 10, 2001·Cancer·C J BradleyC Roberts
Jul 27, 2001·Journal of Health Economics·W G Manning, J Mullahy
Apr 4, 2002·Journal of the National Cancer Institute·Cathy J BradleyCaralee Roberts
Aug 22, 2002·Journal of the National Cancer Institute·Naa Oyo A Kwate
Dec 3, 2003·Health Affairs·Pamela Farley Short, Deborah R Graefe
May 4, 2004·Journal of Health Economics·Melinda Beeuwkes Buntin, Alan M Zaslavsky
Nov 10, 2004·Health Services Research·Ann B NattingerJean L Freeman
Mar 16, 2005·Cancer·Cathy J BradleyCaralee Roberts
Nov 2, 2006·American Journal of Public Health·Cynthia D O'MalleyCarin I Perkins
Apr 10, 2009·PharmacoEconomics·Jonathan D Campbell, Scott D Ramsey
May 23, 2009·Seminars in Oncology·Carey K AndersArchie Bleyer
Nov 13, 2009·PloS One·Hanna FredholmHenrik Lindman
Jan 14, 2011·Journal of the National Cancer Institute·Angela B MariottoMartin L Brown
May 27, 2011·The New England Journal of Medicine·Thomas J Smith, Bruce E Hillner
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Veena ShankaranScott D Ramsey
Sep 7, 2012·Medical Care Research and Review : MCRR·Lindsay M Sabik, Cathy J Bradley
Nov 20, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A Ganz, Laura A Levit
Jan 11, 2014·Journal of Cancer Survivorship : Research and Practice·Theresa H M KeeganUNKNOWN AYA HOPE Study Collaborative Group
Mar 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Reshma JagsiSarah T Hawley
Jun 7, 2014·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Christopher J KingStephen B Thomas
Dec 3, 2014·American Journal of Preventive Medicine·Lindsay M SabikCathy J Bradley

❮ Previous
Next ❯

Citations

Jan 19, 2016·American Journal of Preventive Medicine·Donatus U EkwuemeGery P Guy
Apr 17, 2018·Plastic and Reconstructive Surgery·Jessica I BilligAdeyiza O Momoh
Apr 30, 2020·Breast Cancer Research and Treatment·Justin G TrogdonStephanie B Wheeler
Jul 14, 2017·Breast Cancer Research and Treatment·Justin G TrogdonBenjamin T Allaire
Mar 13, 2021·BMC Health Services Research·Abolhasan AfkarSomayeh Heydari
Aug 18, 2020·Plastic and Reconstructive Surgery. Global Open·Jean-Claude Schwartz
Aug 20, 2021·JNCI Cancer Spectrum·Anagha GogateJustin G Trogdon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.